This suggests that the hyperkalemia in our knock‐in mouse and human PHA2E subjects with the CUL3Δ403‐459 mutation is not caused by reduced ROMK expression in the distal nephron. This evidence concerns the gene KCNJ1 and pseudohypoaldosteronism type 2E.